ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 49 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,000 | 0.0% | 8,448 | +25.5% | 0.00% | – |
| Q2 2023 | $49,000 | +6.5% | 6,734 | +38.5% | 0.00% | – |
| Q1 2023 | $46,000 | +58.6% | 4,863 | +82.6% | 0.00% | – |
| Q4 2022 | $29,000 | – | 2,663 | +4571.9% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 57 | -86.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 406 | +6666.7% | 0.00% | – |
| Q4 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |